Aditi Saha

6PUBLICATIONS
97CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.

|Jan 06, 2026
Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma.

Juan Pablo Alderuccio, Diva Baggio, Sunwoo Han

|Apr 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.

Khushali Jhaveri, Ram Thapa, Dalia Ercan

|Apr 13, 2024
Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.

Lynh Nguyen, Aditi Saha, Andrew Kuykendall

|Mar 29, 2024
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.

Adam S Kittai, David Bond, Ying Huang

|Nov 17, 2023
Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy.

Madiha Iqbal, Deepa Jagadeesh, Julio Chavez

Pageof 1

Frequent Collaborators

4 joint publications

Julio Chavez

2 joint publications

Farhad Khimani

2 joint publications

Narendranath Epperla

2 joint publications

Frederick Locke